Showing results (141-150 of 469) with videos related to
Sort By:
Pageof 47
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 4, 2014
Pregnancy-associated plasma protein-A expression in human breast cancerAaron S Mansfield, Daniel W Visscher, Steven N Hart, et al.Breast Cancer Research : BCR|March 14, 2012
Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivoAshwani Khurana, Hiedi McKean, Hyunseok Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2007
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study GroupRainer Porschen, Hendrik-Tobias Arkenau, Stephan Kubicka, et al.The Oncologist|December 19, 2019
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal CancerMohamed E Salem, Francesca Battaglin, Richard M Goldberg, et al.The Journal of Supportive Oncology|April 7, 2007
Symptom control trials: a 20-year experienceCharles L Loprinzi, Debra L Barton, Aminah Jatoi, et al.Seminars in Oncology|October 22, 2008
North Central Cancer Treatment Group--achievements and perspectivesAxel Grothey, Alex A Adjei, Steve R Alberts, et al.The Oncologist|September 4, 2009
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort studyMark Kozloff, Marianne Ulcickas Yood, Jordan Berlin, et al.Pharmacoepidemiology and Drug Safety|May 17, 2014
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort studyAxel Grothey, E Dawn Flick, Allen L Cohn, et al.Menopause (New York, N.Y.)|May 21, 2020
Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trialHarriet Richardson, Vikki Ho, Romain Pasquet, et al.Breast Cancer (Tokyo, Japan)|October 18, 2021
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerMasato Takahashi, Eriko Tokunaga, Joji Mori, et al.Pageof 47